Home/ Peptides/ SS-31

SS-31

Mitochondrial · Longevity Subcutaneous Injectable

SS-31 (also called Elamipretide) is a frontier-level longevity intervention that targets the inner mitochondrial membrane directly. It reduces oxidative damage and preserves energy production in aging or stressed cells — particularly useful for chronic fatigue, heart-tissue support, and advanced longevity stacks.

Best for: Mitochondrial dysfunction, chronic fatigue, neurodegenerative concerns, advanced longevity protocols.

Book Consult→ Get discounts with memberships →
Lab-guided protocolsPersonalized dosingProvider-led oversightIn-clinic & telehealth Lab-guided protocolsPersonalized dosingProvider-led oversightIn-clinic & telehealth
Frequently Asked
What clients want to know about SS-31

The questions, answered.

  • Targets the inner mitochondrial membrane directly — protects cardiolipin.
  • Reduces oxidative damage at the cellular powerhouse.
  • Supports cardiac and neural tissue in aging populations.
  • Improves exercise capacity in mitochondrial-stressed individuals.
  • May ease chronic fatigue rooted in cellular energy deficit.
  • Studied in cardiology and neurology trials.
  • Cardiolipin binding: stabilizes the inner mitochondrial membrane.
  • Electron transport chain efficiency: reduces electron leakage.
  • ROS scavenging at the source rather than downstream.
  • Bioenergetic restoration in stressed tissue.
  • Weeks 1–2: Subtle energy improvement and reduced exercise-related fatigue.
  • Weeks 4–6: Cellular markers improve where measured; subjective stamina rises.
  • Weeks 8–12: Advanced mitochondrial benefits consolidate; protocol cycles per provider plan.
  • Injection-site reactions.
  • Mild GI changes early in protocol.
  • Transient fatigue as mitochondria reorganize.
  • Use within an advanced protocol — not a starting peptide.
  • Pair with MOTS-C for layered mitochondrial benefit.
  • Reassess with labs at 12 weeks to confirm objective response.
  • Cycle as guided by your provider.
  • Pregnancy or breastfeeding.
  • Active malignancy without oncology oversight.
  • Known peptide allergy.
Important Note The FDA's position on peptides continues to evolve. Availability of specific compounds may change, and not all peptides discussed are currently offered at every visit. Book a consultation with our provider team to discuss your goals, current options, and what's appropriate for you.
Related Protocols
Often paired or layered alongside SS-31

Layered with intention.

Repair & Recovery
BPC-157
Body Protective Compound
Repair & Recovery
TB-500
Thymosin Beta-4 Fragment
Repair & Recovery · Immune
KPV
Alpha-MSH Fragment
— Begin

Precision protocols.
Designed around you.

Every TAI peptide protocol is lab-guided and provider-led. Start with biomarkers, design around your goals, refine at intervals. Available in-clinic and via telehealth.

Book Consult→ Membership pricing →